Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. (XLO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · XLO · as of Jun 9, 2026
Key Statistics
Explore Xilio Therapeutics, Inc. Data
xlo stock data · financialsCompetitors & Peers
xlo competitorsXLO
ALGS
ATNM
FGEN
KZR
LVTXAbout Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to crafting immunotherapies aimed at strengthening the immune systems of cancer patients. A key part of their pipeline is XTX1…
what is xilio therapeutics, inc. · xlo stock overview · xilio therapeutics, inc. company profile · who is xilio therapeutics, inc. ceo · xlo NASDAQ · xilio therapeutics, inc. headquarters · xilio therapeutics, inc. business segments
About Stock Overview & Key Data
Xilio Therapeutics, Inc. (XLO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 22, 2021. As of the latest trading session, XLO stock price is $7.68, with a market capitalization of $45.9M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Xilio Therapeutics, Inc. (XLO) stock price is $7.68. The stock is traded on NASDAQ under the ticker symbol XLO. The 52-week range is $6.47 – $12.74.